Colorectal Cancer Trial, Recruiting NCT07086833 Sponsor: Purdue University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07086833
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 45 and 75 years old
  • People who are up to date with bowel cancer screening (colonoscopy) and have been found to have a higher risk of bowel cancer — specifically, those who have had 3 or more growths called adenomatous polyps, or at least one polyp larger than 1 cm, in the past 5 years
  • People who identify as Black or Non-Hispanic White
  • Women who have not had a menstrual period for at least six months
  • People willing to provide mouth rinse and stool samples for the study
  • People willing to complete records of what they eat over a 24-hour period

Who may not be able to join:

  • People who have taken antibiotics in the last 6 months
  • People who have abnormal bowel movement patterns (confirm with trial site)
  • People who have had an organ transplant at any point
  • People who use illicit drugs, smoke tobacco, or take dietary supplements
  • People who have taken pre- or probiotic products in the last two months
  • People who have received cancer treatment in the past 12 months
  • People who have bowel cancer or a known genetic predisposition to bowel cancer
  • People whose starting body weight is over 450 pounds (approximately 204 kg)
  • People who have gained or lost more than 4 kg in the 3 months before the study
  • People with significant food allergies, strong food preferences, or those following a therapeutic or vegetarian diet
  • People who have had a menstrual period within the last 6 months
  • People who are unable to keep a food diary for 7 days in a row during the screening period, even after being shown how
  • People with significant medical conditions (confirm with trial site for specifics)
  • People with a history of an eating disorder
  • People with alcoholism
  • People under 18 years of age

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 765-494-1860

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Purdue University
Registry
ClinicalTrials.gov
Start date
18 August 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Colonic inflammation; Fecal microbial content; Systemic markers of inflammation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov